Natriuretic peptide release during exercise in patients with valvular heart disease: A systematic review

Abstract

Aim: Serum biomarkers have a potential role in the risk stratification of patients with heart valve disease and may help determine the optimal timing of intervention. Much of the published literature relates to biomarker sampling in a resting state, but the relationship of exercise biomarkers is less well described. We performed a systematic review to examine the significance of exercise natriuretic peptides on echocardiographic variables and cardiovascular events, in valvular heart disease. Methods:A search for studies that assessed exercise biomarkers in patients with moderate to severe valve lesions was performed. We examined the relationship between rest and exercise BNP and also the endpoints of symptoms, haemodynamic or echocardiographic variables and clinical outcomes.Results: Eleven prospective studies were identified (844 participants). 61% were male and the mean age was 55.2 ± 9.6 years. The majority of the blood samples were taken at baseline and within 3 minutes of stopping exercise. There was a significant increase in exercise BNP compared with rest, in patients with aortic stenosis, mitral regurgitation and mitral stenosis. Elevated exercise BNP levels correlated with mean gradient and left atrial area, and there was a relationship between a higher exercise BNP and a blunted blood pressure response, in aortic stenosis. Furthermore, exercise BNP was independently associated with cardiac events, over and above resting values, in patients with mitral regurgitation and aortic stenosis. How to cite this article: Badiani S, van Zalen J, Althunayyan A, et al. Natriuretic peptide release during exercise in patients with valvular heart disease: A systematic review. Int J Clin Pract.

Sex Differences in Epidemiology, Morphology, Mechanisms, and Treatment of Mitral Valve Regurgitation

“…Finally, natriuretic peptides are the most widely used markers of cardiac volume overload in daily clinical practice. Their application in the assessment of patients with valvular heart disease is emerging, and many studies have shown a strong correlation between natriuretic peptides and clinical outcomes in patients with symptomatic and asymptomatic MR [ 40 , 41 ]. Although specific cut-offs have not yet been defined, they can be another useful tool for implementing the management of patients with MR when indication for intervention is not clear.…”

Heart Failure: Is There an Ideal Biomarker?

“…This is explained further in the specific sections and particularly concerns HFpEF. Also, in heart valve disease, biomarkers could play a role in the stratification of patients’ risk and help identify the optimal time of cardiac surgery by identifying the early stages of HF and avoiding further structural alteration [ 19 ]. Other biomarkers evaluated as predictors of adverse outcomes are galectin-3, growth differentiation factor 15, mid-regional pro-adrenomedullin, and markers of renal dysfunction.…”

“…The knowledge of the effects and mechanisms of action of NPs is fundamental to investigating the electrophysiological consequences, certainly less studied, but which could prove significant considering the increase in electrical conduction and heart rate and, therefore, in oxygen consumption induced by the activation of NPR-A and NPR-B receptors and by the inhibition of phosphodiesterase 3 (PDE3) [ 43 ]. Also, in heart valve disease, the diastolic stretching that occurs following blood regurgitation in mitral and aortic insufficiency and the pressure overload typical of aortic stenosis determine the production of BNP, expression of cardiac decompensation and could independently identify individuals more at risk of cardiac events, therefore deserving of closer follow-up and any further cardiological investigations [ 19 , 44 ]. The increasing importance of NPs in the diagnosis, management, severity, and prognostic implications of HF has recently been the subject of great attention by the major scientific societies concerned with HF—Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society—in the actions of the so-called Trilateral Cooperation Project [ 45 ].…”

Mitral Regurgitation and Floppy Mitral Valve in the Internist’s Practice

“…Например, повышается уровень циркулирующих провоспалительных цитокинов [20]. В ответ на объёмную нагрузку повышаются натрийуретические пептиды [21]. Что касается клинических проявлений ишемии -их меньше, чем при других пороках.…”

“…За один год примерно 8 % пациентов с МР достигают того состояния, когда требуется хирургическое вмешательство. И, поскольку есть такая ситуация, когда симптомы не распознаются, или игнорируются, весьма полезно исследование натрийуретическго пептида, который объективно зависит от преднагрузки, помогает принять тактическое решение [21]. Фракция выброса ЛЖ зависит от нагрузки, и зачастую переоценивается.…”